Case of ketoacidosis by a sodium-glucose cotransporter 2 inhibitor in a diabetic patient with a low-carbohydrate diet

被引：85

作者：

Hayami, Tomohide ^{[1
]}

Kato, Yoshiro ^{[1
]}

Kamiya, Hideki ^{[1
]}

Kondo, Masaki ^{[1
]}

Naito, Ena ^{[1
]}

Sugiura, Yukako ^{[1
]}

Kojima, Chika ^{[1
]}

Sato, Sami ^{[1
]}

Yamada, Yuichiro ^{[1
]}

Kasagi, Rina ^{[1
]}

Ando, Toshihito ^{[1
]}

Noda, Saeko ^{[1
]}

Nakai, Hiromi ^{[1
]}

Takada, Eriko ^{[1
]}

Asano, Emi ^{[1
]}

Motegi, Mikio ^{[1
]}

Watarai, Atsuko ^{[2
]}

Kato, Koichi ^{[3
]}

Nakamura, Jiro ^{[1
]}

机构：

[1] Aichi Med Univ, Sch Med, Dept Internal Med, Div Diabet, Nagakute, Aichi 48011, Japan

[2] Chubu Rosai Hosp, Ctr Prevent Med, Nagoya, Aichi, Japan

[3] Aichi Gakuin Univ, Sch Pharm, Lab Med, Nagoya, Aichi 464, Japan

来源：

JOURNAL OF DIABETES INVESTIGATION | 2015年 / 6卷 / 05期

关键词：

Ketoacidosis; Low-carbohydrate diet; Sodium-glucose cotransporter2 inhibitor; INSULIN SENSITIVITY; DAPAGLIFLOZIN;

D O I：

10.1111/jdi.12330

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We present a case of a 32-year-old diabetic woman with Prader-Willi syndrome who developed severe ketoacidosis caused by a sodium-glucose cotransporter2 (SGLT2) inhibitor, a novel class of antihyperglycemic agents, during a strict low-carbohydrate diet. At admission, a serum glucose level of 191mg/dL was relatively low, though laboratory evaluations showed severe ketoacidosis. This is the first report of ketoacidosis caused by a SGLT2 inhibitor. It is necessary to not only pay attention when using a SGLT2 inhibitor in patients following a low-carbohydrate diet, but also to start a low-carbohydrate diet in patients treated with a SGLT2 inhibitor because of a high risk for developing ketoacidosis.

引用

页码：587 / 590

页数：4

共 9 条

[1] Efficacy and safety of low-carbohydrate diets - A systematic review [J].

Bravata, DM ;

Sanders, L ;

Huang, J ;

Krumholz, HM ;

Olkin, I ;

Gardner, CD ;

Bravata, DM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (14) :1837-1850

[2] A life-threatening complication of Atkins diet [J].

Chen, TY ;

Smith, W ;

Rosenstock, JL ;

Lessnau, KD .

LANCET, 2006, 367 (9514) :958-958

[3] Renal sodium glucose cotransporter 2 inhibitors as a novel therapeutic approach to treatment of type 2 diabetes: Clinical data and mechanism of action [J].

Fujita, Yoshihito ;

Inagaki, Nobuya .

JOURNAL OF DIABETES INVESTIGATION, 2014, 5 (03) :265-275

[4] Management of hyperglycemic crises in patients with diabetes [J].

Kitabchi, AE ;

Umpierrez, GE ;

Murphy, MB ;

Barrett, EJ ;

Kreisberg, RA ;

Malone, JI ;

Wall, BM .

DIABETES CARE, 2001, 24 (01) :131-153

[5] Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production [J].

Merovci, Aurora ;

Solis-Herrera, Carolina ;

Daniele, Giuseppe ;

Eldor, Roy ;

Fiorentino, Teresa Vanessa ;

Tripathy, Devjit ;

Xiong, Juan ;

Perez, Zandra ;

Norton, Luke ;

Abdul-Ghani, Muhammad A. ;

DeFronzo, Ralph A. .

JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (02) :509-514

[6] Changes in Insulin Sensitivity and Insulin Secretion with the Sodium Glucose Cotransporter 2 Inhibitor Dapagliflozin [J].

Mudaliar, Sunder ;

Henry, Robert R. ;

Boden, Guenther ;

Smith, Steven ;

Chalamandaris, Alexandros-Georgios ;

Duchesne, Dominique ;

Iqbal, Nayyar ;

List, James .

DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 (03) :137-144

[7] Luseogliflozin for the treatment of type 2 diabetes [J].

Seino, Yutaka .

EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (18) :2741-2749

[8] Ketoacidosis during a low-carbohydrate diet [J].

Shah, P ;

Isley, WL .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01) :97-98

[9] Analysis and a long-term follow up of ketosis-onset Japanese NIDDM patients [J].

Tanaka, K ;

Moriya, T ;

Kanamori, A ;

Yajima, Y .

DIABETES RESEARCH AND CLINICAL PRACTICE, 1999, 44 (02) :137-146

← 1 →